TUSC2 Polyclonal antibody

TUSC2 Polyclonal Antibody for ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IF, ELISA

Conjugate

Unconjugated

Cat no : 11538-1-AP

Synonyms

PDAP2, PAP, LGCC, Fus-1 protein, FUS1



Product Information

11538-1-AP targets TUSC2 in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen TUSC2 fusion protein Ag2118
Full Name tumor suppressor candidate 2
Calculated Molecular Weight 12 kDa
Observed Molecular Weight 10-12 kDa
GenBank Accession NumberBC023976
Gene Symbol TUSC2
Gene ID (NCBI) 11334
RRIDAB_10699869
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

FUS1 (or TUSC2) gene is a highly conserved lung cancer candidate gene, which was identified in the 120 kb 3p21.3 critical region contained in nested lung and breast cancer homozygous deletions. Overexpression of FUS1 gene leads to G1 arrest and growth inhibition of lung cancer cells (PMID: 11593436). The encoded Fusion-1 protein was down-regulated, mutated or lost in the majority of inflammatory thoracic malignancies. It has been evidenced that Fusion-1 establishes its immune- and tumour-suppressive activities via regulation of mitochondrial homeostasis (PMID: 22513871). In addition, myristoylation is found to be required for Fusion-1-mediated tumor-suppressing activity and suggest a novel mechanism for the inactivation of tumor suppressors in lung cancer and a role for deficient posttranslational modification in tumor suppressor-gene-mediated carcinogenesis (PMID: 15126327).

Publications

SpeciesApplicationTitle
human,mouseWB,IHC,IF

Cancer Lett

NEDD4 degrades TUSC2 to promote glioblastoma progression.

Authors - Tadas K Rimkus
humanWB,IHC

Oncotarget

TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.

Authors - Francesca Maria Orlandella